A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non-Small-Cell Lung Cancer

Malcolm D Mattes1, Wolfgang A Weber, Amanda Foster

  • 1*Department of Radiation Oncology, West Virginia University, Morgantown, West Virginia; Departments of †Radiology and ‡Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; §Department of Radiation Oncology, New York Methodist Hospital, Brooklyn, New York; and Departments of ‖Epidemiology and Biostatistics and ¶Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

Summary

Accurate assessment of lymph node (LN) involvement in non-small-cell lung cancer is crucial for staging. Adenocarcinoma histology, higher LN SUVmax, and higher LN risk category independently predict malignant LN involvement.

Related Concept Videos